Home | dermcity

VIDEO: Topical calcineurin inhibitor use for AD shows no cancer risk, according to study

According to a new study, topical calcineurin inhibitors such as pimecrolimus and tacrolimus did not increase risk in AD patients.

AD prophylaxis in high-risk infants: Emollient emulsions may produce best outcomes

An assessment of various types of skin moisturizers suggests an emollient emulsion may be the most effective option to help prevent...

Highest risk of multiple primary melanomas from indoor tanning

Findings from a case-control study show that a history of indoor tanning is the strongest risk factor for the development of multiple...

VIDEO: Many pediatric HS patients do not meet diagnostic criteria, new study shows

Over one third of pediatric patients with HS did not meet all three major diagnostic criteria at the time of diagnosis.

Study shows high percentage of ‘natural’ skin care products contain allergens

Nearly 90% of 1,651 so-called ‘natural’ personal care products contain at least one known allergen, according to a new study from...

Nivolumab shows promise in advanced cutaneous squamous cell carcinoma

Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...

VIDEO: Study shows HS patients who feel stigmatized report worse QoL, mental health outcomes

Patients with HS who report feelings of stigmatization from their condition had worse QoL and higher levels of depression.

Skin disease may be exacerbated by remnants of third-hand smoke

The results of a small study indicate that third-hand smoke (THS)—the incinerated particles of smoke that settle on clothing and other...

1

it's where dermatology lives